Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

Objective. Renal biopsy contributes to the diagnosis, follow-up, and treatment of many rheumatic conditions. This study assessed the diagnostic role and safety of renal biopsies in a tertiary rheumatology clinic. Methods. Renal biopsies performed between June 2020 and December 2022 were screened,...

Full description

Bibliographic Details
Main Authors: R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes
Format: Article
Language:English
Published: PAGEPress Publications 2023-09-01
Series:Reumatismo
Subjects:
Online Access:https://www.reumatismo.org/index.php/reuma/article/view/1586
_version_ 1827814997166653440
author R. Deniz
N. Güner
Ş.A. Ekmen
İ.N. Mutlu
D.S. Özgür
B. Karaalioğlu
G. Akkuzu
F. Yıldırım
K. Kalkan
G. Güzelant-Özköse
B. İnce
M. Erdoğan
Y. Özlük
I. Kılıçaslan
C. Bes
author_facet R. Deniz
N. Güner
Ş.A. Ekmen
İ.N. Mutlu
D.S. Özgür
B. Karaalioğlu
G. Akkuzu
F. Yıldırım
K. Kalkan
G. Güzelant-Özköse
B. İnce
M. Erdoğan
Y. Özlük
I. Kılıçaslan
C. Bes
author_sort R. Deniz
collection DOAJ
description Objective. Renal biopsy contributes to the diagnosis, follow-up, and treatment of many rheumatic conditions. This study assessed the diagnostic role and safety of renal biopsies in a tertiary rheumatology clinic. Methods. Renal biopsies performed between June 2020 and December 2022 were screened, and demographic, clinical, histopathological, and safety data were collected from patient records. Results. In this study, 33 males and 38 females were included. Except for 1 patient who received acetylsalicylic acid, antiaggregant, and/or anticoagulant drugs were stopped before the biopsy. Complications included a decrease of hemoglobin in 8 patients (11.3%) and microscopic hematuria in 40 patients (56.3%). Control ultrasonography was performed in 16 patients (22.5%), and a self-limiting hematoma was found in 4 of them (5.6%) without additional complications. While less than 10 glomeruli were obtained in 9 patients (9.9%), diagnosis success was 94.4%. Histopathological data were consistent with one of the pre-biopsy diagnoses in 54 of 67 cases (80.6%) but showed discrepancies in 19.4% (n=13) of patients. A repeat biopsy was performed in 7 patients for re-staging or insufficient biopsy. Conclusions. Renal biopsy significantly contributes to rheumatology practice, especially in patients with complex clinical and laboratory findings or in whom different treatments can be given according to the presence, severity, and type of renal involvement. Although the possibility of obtaining insufficient tissue and the need for re-staging and repeat biopsy in the follow-up might be expected, complication risk does not seem to be a big concern. Renal biopsy often evidenced discrepancies between pre-biopsy diagnosis and histopathological findings.
first_indexed 2024-03-11T23:53:48Z
format Article
id doaj.art-21fccfdd98e045eda8d1242045568faa
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-03-11T23:53:48Z
publishDate 2023-09-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-21fccfdd98e045eda8d1242045568faa2023-09-18T19:54:32ZengPAGEPress PublicationsReumatismo0048-74492240-26832023-09-0175310.4081/reumatismo.2023.1586Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseasesR. Deniz0N. Güner1Ş.A. Ekmen2İ.N. Mutlu3D.S. Özgür4B. Karaalioğlu5G. Akkuzu6F. Yıldırım7K. Kalkan8G. Güzelant-Özköse9B. İnce10M. Erdoğan11Y. Özlük12I. Kılıçaslan13C. Bes14Department of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Internal Medicine, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Internal Medicine, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Radiology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbulDepartment of Pathology, Faculty of Medicine, University of İstanbulDepartment of Pathology, Faculty of Medicine, University of İstanbulDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul Objective. Renal biopsy contributes to the diagnosis, follow-up, and treatment of many rheumatic conditions. This study assessed the diagnostic role and safety of renal biopsies in a tertiary rheumatology clinic. Methods. Renal biopsies performed between June 2020 and December 2022 were screened, and demographic, clinical, histopathological, and safety data were collected from patient records. Results. In this study, 33 males and 38 females were included. Except for 1 patient who received acetylsalicylic acid, antiaggregant, and/or anticoagulant drugs were stopped before the biopsy. Complications included a decrease of hemoglobin in 8 patients (11.3%) and microscopic hematuria in 40 patients (56.3%). Control ultrasonography was performed in 16 patients (22.5%), and a self-limiting hematoma was found in 4 of them (5.6%) without additional complications. While less than 10 glomeruli were obtained in 9 patients (9.9%), diagnosis success was 94.4%. Histopathological data were consistent with one of the pre-biopsy diagnoses in 54 of 67 cases (80.6%) but showed discrepancies in 19.4% (n=13) of patients. A repeat biopsy was performed in 7 patients for re-staging or insufficient biopsy. Conclusions. Renal biopsy significantly contributes to rheumatology practice, especially in patients with complex clinical and laboratory findings or in whom different treatments can be given according to the presence, severity, and type of renal involvement. Although the possibility of obtaining insufficient tissue and the need for re-staging and repeat biopsy in the follow-up might be expected, complication risk does not seem to be a big concern. Renal biopsy often evidenced discrepancies between pre-biopsy diagnosis and histopathological findings. https://www.reumatismo.org/index.php/reuma/article/view/1586Renal biopsyvasculitisinterventional radiologyrenal pathologycomplications
spellingShingle R. Deniz
N. Güner
Ş.A. Ekmen
İ.N. Mutlu
D.S. Özgür
B. Karaalioğlu
G. Akkuzu
F. Yıldırım
K. Kalkan
G. Güzelant-Özköse
B. İnce
M. Erdoğan
Y. Özlük
I. Kılıçaslan
C. Bes
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
Reumatismo
Renal biopsy
vasculitis
interventional radiology
renal pathology
complications
title Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
title_full Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
title_fullStr Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
title_full_unstemmed Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
title_short Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
title_sort discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases
topic Renal biopsy
vasculitis
interventional radiology
renal pathology
complications
url https://www.reumatismo.org/index.php/reuma/article/view/1586
work_keys_str_mv AT rdeniz discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT nguner discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT saekmen discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT inmutlu discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT dsozgur discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT bkaraalioglu discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT gakkuzu discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT fyıldırım discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT kkalkan discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT gguzelantozkose discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT bince discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT merdogan discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT yozluk discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT ikılıcaslan discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases
AT cbes discrepanciesbetweenclinicalandpathologicalfindingsseenatrenalbiopsyinrheumatologicaldiseases